Related Experiment Videos

Prolactin activates Ras via signaling proteins SHC, growth factor receptor bound 2, and son of sevenless

R A Erwin1, R A Kirken, M G Malabarba

  • 1Biological Carcinogenesis and Development Program, Program Resources, Inc./DynCorp, National Cancer Institute, Frederick Cancer Research and Development Center, Maryland 21702, USA.

Endocrinology
|August 1, 1995
PubMed

Insights

Prolactin (PRL) activates the Ras signaling pathway in cancer cells, a crucial step for growth and differentiation. This study demonstrates PRL-induced Ras activation via SHC, growth factor receptor bound 2, and son of sevenless, highlighting a common signaling mechanism.

Area of Science:

  • Cellular Biology
  • Molecular Signaling
  • Cancer Research

Background:

  • Prolactin (PRL) receptor activation involves early signaling mediators like Janus kinase (JAK) and SRC family tyrosine kinases.
  • Understanding PRL's signal transduction pathways is key to its role in growth and differentiation.

Purpose of the Study:

  • To investigate the role of the Ras protein in prolactin (PRL) signaling.
  • To identify the specific mediators involved in PRL-induced Ras activation.

Main Methods:

  • Utilized rat Nb2-SP lymphoma cells and human breast cancer cell lines.
  • Assessed Ras activation by measuring its GTP-bound state.
  • Investigated tyrosine phosphorylation and protein-protein interactions of signaling molecules like SHC, growth factor receptor bound 2 (Grb2), and son of sevenless (SOS).

Main Results:

  • PRL significantly increased the GTP-bound state of Ras by 2.0-fold in Nb2-SP cells (P < 0.01).
  • PRL induced tyrosine phosphorylation and membrane association of SHC, leading to its binding with Grb2 and SOS.
  • PRL did not appear to regulate Ras via VAV or p120 Ras-GAP, as evidenced by the lack of tyrosine phosphorylation.

Conclusions:

  • Prolactin activates Ras in Nb2 cells through the recruitment of SHC, Grb2, and SOS.
  • SHC-mediated Ras activation by PRL is a prevalent signaling strategy, observed in human breast cancer cell lines.

Related Concept Videos